About Pharmerit_WPadmin

This author has not yet filled in any details.
So far Pharmerit_WPadmin has created 234 blog entries.

Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?

Payers are concerned that one-off “cures” bring great uncertainty with the consequential risk of incorrect adoption decisions, and significant budget impact from large one-off payments.

2019-06-19T12:42:31-04:00June 19th, 2019|

Comparison of Quality Of Life Measurements: EQ-5D-5L versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis.

Comparison of Quality Of Life Measurements: EQ-5D-5L versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis. INTRODUCTION There is a lack of performance comparisons of the generic quality of [...]

2019-06-12T12:48:30-04:00June 11th, 2019|

Comparative Efficacy and Safety of Dolutegravir Relative to Common Core Agents in Treatment-Naïve Patients Infected with HIV-1: a Systematic Review and Network Meta-Analysis

Comparative Efficacy and Safety of Dolutegravir Relative to Common Core Agents in Treatment-Naïve Patients Infected with HIV-1: A Systematic Review and Network Meta-Analysis BACKGROUND Network meta-analyses (NMAs) provide comparative treatment [...]

2019-06-12T12:53:02-04:00June 7th, 2019|

Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis

Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis INTRODUCTION Evidence supports the clinical benefits of early aggressive biologic treatment [...]

2019-06-12T12:58:35-04:00June 7th, 2019|

Cost-Effectiveness of a Fixed Combination of Netupitant and Palonosetron (NEPA) Relative to Aprepitant Plus Granisetron (APR + GRAN) for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV): A Trial-Based Analysis

Chemotherapy-induced nausea and vomiting (CINV) are among the most common and debilitating side effects patients experience during chemotherapy and are associated with considerable acute care use and healthcare cost.

2019-06-12T13:02:43-04:00June 7th, 2019|

Long-Term Assessment of Healthcare Utilization Five Years After Respiratory Syncytial Virus Infection in US Infants

Long-Term Assessment of Healthcare Utilization Five Years After Respiratory Syncytial Virus Infection in US Infants. BACKGROUND Respiratory syncytial virus (RSV) is the primary cause of respiratory tract infections in infants; [...]

2019-06-12T12:27:08-04:00June 7th, 2019|

Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson’s Disease: Results from a pooled meta-analysis

To evaluate short-term and long-term impact of carbidopa-levodopa enteral suspension (CLES) on quality of life (QoL) and activities of daily living (ADL) in patients with advanced Parkinson’s Disease (APD).

2019-05-31T12:51:31-04:00May 31st, 2019|